UK markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.14-0.06 (-0.97%)
At close: 4:00PM EDT
6.00 -0.14 (-2.28%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
30/09/2018
Total revenue
3,222
1,715
2,908
1,407
Operating expenses
Research development
135,135
134,888
105,418
36,150
Selling general and administrative
34,824
34,972
39,452
22,790
Total operating expenses
170,183
169,860
144,870
58,940
Operating income or loss
-166,961
-168,145
-141,962
-57,533
Interest expense
-
-
-
12.667
Total other income/expenses net
-5,340
1,352
412
3,970
Income before tax
-172,143
-166,257
-139,008
-52,031
Income tax expense
-25,527
-24,163
-15,159
-7,280
Income from continuing operations
-146,616
-142,094
-123,849
-44,751
Net income
-146,616
-142,094
-123,849
-44,751
Net income available to common shareholders
-146,616
-142,094
-123,849
-44,751
Basic EPS
-
-2.76
-2.88
-0.99
Diluted EPS
-
-2.76
-2.88
-0.99
Basic average shares
-
51,558
43,066
31,557
Diluted average shares
-
51,558
43,066
31,557
EBITDA
-
-162,487
-137,351
-55,824